Clinical Trial Update: Efficacy and Safety of ATL-962 in Obese Diabetics [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of ATL-962 in patients with Type 2 diabetes mellitus and obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• ATL-962

Snippet

Sponsor: Alizyme | Conditions: Non-Insulin-Dependent Diabetes Mellitus, Obesity | Phase 2 | Status: COMPLETED